Janni W, Rack BK, Gluz O. et al.
Pooled analysis of two randomized phase III trials (PlanB/SuccessC) comparing
six cycles of docetaxel and cyclophosphamide to sequential anthracycline taxane
chemotherapy in patients with intermediate and high risk HER2-negative early
breast cancer (n=5,923).
J Clin Oncol. 2018
36. (suppl; abstr 522)
Download Bibliographical Data